These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

284 related items for PubMed ID: 35384876

  • 1. Using pan-TRK and RET Immunohistochemistry for the Detection of Fusion Types of Salivary Gland Secretory Carcinoma.
    Su YJ, Lee YH, Jin YT, Hsieh MS.
    Appl Immunohistochem Mol Morphol; 2022 Apr 01; 30(4):264-272. PubMed ID: 35384876
    [Abstract] [Full Text] [Related]

  • 2. Pan-TRK Immunohistochemistry Is Highly Correlated With NTRK3 Gene Rearrangements in Salivary Gland Tumors.
    Csanyi-Bastien M, Lanic MD, Beaussire L, Ferric S, François A, Meseure D, Jardin F, Wassef M, Ruminy P, Laé M.
    Am J Surg Pathol; 2021 Nov 01; 45(11):1487-1498. PubMed ID: 33899788
    [Abstract] [Full Text] [Related]

  • 3. Pan-tropomyosin receptor kinase immunoreactivity, ETV6-NTRK3 fusion subtypes, and RET rearrangement in salivary secretory carcinoma.
    Yamamoto H, Nozaki Y, Sugii A, Taguchi K, Hongo T, Jiromaru R, Sato M, Nakano T, Hashimoto K, Fujiwara M, Oda Y.
    Hum Pathol; 2021 Mar 01; 109():37-44. PubMed ID: 33301751
    [Abstract] [Full Text] [Related]

  • 4. Pan-Trk immunohistochemistry reliably identifies ETV6-NTRK3 fusion in secretory carcinoma of the salivary gland.
    Bell D, Ferrarotto R, Liang L, Goepfert RP, Li J, Ning J, Broaddus R, Weber RS, El-Naggar AK.
    Virchows Arch; 2020 Feb 01; 476(2):295-305. PubMed ID: 31423558
    [Abstract] [Full Text] [Related]

  • 5. Pan-Trk immunohistochemistry is a sensitive and specific ancillary tool for diagnosing secretory carcinoma of the salivary gland and detecting ETV6-NTRK3 fusion.
    Xu B, Haroon Al Rasheed MR, Antonescu CR, Alex D, Frosina D, Ghossein R, Jungbluth AA, Katabi N.
    Histopathology; 2020 Feb 01; 76(3):375-382. PubMed ID: 31448442
    [Abstract] [Full Text] [Related]

  • 6. Expanding the Molecular Spectrum of Secretory Carcinoma of Salivary Glands With a Novel VIM-RET Fusion.
    Skálová A, Banečkova M, Thompson LDR, Ptáková N, Stevens TM, Brcic L, Hyrcza M, Michal M, Simpson RHW, Santana T, Michal M, Vaněček T, Leivo I.
    Am J Surg Pathol; 2020 Oct 01; 44(10):1295-1307. PubMed ID: 32675658
    [Abstract] [Full Text] [Related]

  • 7. Immunohistochemistry with a pan-TRK antibody distinguishes secretory carcinoma of the salivary gland from acinic cell carcinoma.
    Hung YP, Jo VY, Hornick JL.
    Histopathology; 2019 Jul 01; 75(1):54-62. PubMed ID: 30801752
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Pan-Trk Immunohistochemistry Is an Efficient and Reliable Screen for the Detection of NTRK Fusions.
    Hechtman JF, Benayed R, Hyman DM, Drilon A, Zehir A, Frosina D, Arcila ME, Dogan S, Klimstra DS, Ladanyi M, Jungbluth AA.
    Am J Surg Pathol; 2017 Nov 01; 41(11):1547-1551. PubMed ID: 28719467
    [Abstract] [Full Text] [Related]

  • 11. High-grade salivary gland carcinoma with the ETV6-NTRK3 gene fusion: A case report and literature review of secretory carcinoma with high-grade transformation.
    Asai S, Sumiyoshi S, Yamada Y, Tateya I, Nagao T, Minamiguchi S, Haga H.
    Pathol Int; 2021 Jun 01; 71(6):427-434. PubMed ID: 33848386
    [Abstract] [Full Text] [Related]

  • 12. Novel gene fusions in secretory carcinoma of the salivary glands: enlarging the ETV6 family.
    Guilmette J, Dias-Santagata D, Nosé V, Lennerz JK, Sadow PM.
    Hum Pathol; 2019 Jan 01; 83():50-58. PubMed ID: 30130630
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Mammary Analogue Secretory Carcinoma of Salivary Glands: Molecular Analysis of 25 ETV6 Gene Rearranged Tumors With Lack of Detection of Classical ETV6-NTRK3 Fusion Transcript by Standard RT-PCR: Report of 4 Cases Harboring ETV6-X Gene Fusion.
    Skálová A, Vanecek T, Simpson RH, Laco J, Majewska H, Baneckova M, Steiner P, Michal M.
    Am J Surg Pathol; 2016 Jan 01; 40(1):3-13. PubMed ID: 26492182
    [Abstract] [Full Text] [Related]

  • 15. EPR17341 and A7H6R pan-TRK Immunohistochemistry Result in Highly Different Staining Patterns in a Series of Salivary Gland Tumors.
    Guibourg B, Cloarec E, Conan-Charlet V, Quintin-Roué I, Grippari JL, Le Flahec G, Marcorelles P, Uguen A.
    Appl Immunohistochem Mol Morphol; 2020 Oct 01; 28(9):719-724. PubMed ID: 32187023
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Detection of NTRK fusions in glioblastoma: fluorescent in situ hybridisation is more useful than pan-TRK immunohistochemistry as a screening tool prior to RNA sequencing.
    Bourhis A, Caumont C, Quintin-Roué I, Magro E, Dissaux G, Remoué A, Le Noac'h P, Douet-Guilbert N, Seizeur R, Tyulyandina A, Schick U, Merlio JP, Marcorelles P, Cappellen D, Uguen A.
    Pathology; 2022 Feb 01; 54(1):55-62. PubMed ID: 34518039
    [Abstract] [Full Text] [Related]

  • 19. Atypical/unbalanced ETV6/NTRK3 rearrangement in salivary secretory carcinoma with a focus on the incidence, the patterns, and the clinical implications.
    Sun J, Li J, Tian Z, Zhang C, Xia R, He Y.
    J Oral Pathol Med; 2022 Sep 01; 51(8):721-729. PubMed ID: 36087274
    [Abstract] [Full Text] [Related]

  • 20. Pan-tumor screening for NTRK gene fusions using pan-TRK immunohistochemistry and RNA NGS fusion panel testing.
    Koehne de González A, Mansukhani MM, Fernandes H, Hsiao SJ.
    Cancer Genet; 2022 Apr 01; 262-263():47-52. PubMed ID: 35007853
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.